This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $750,002 to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, to develop robust and equitable clinical decision support systems for glaucoma detection and progression prediction. The 4-year project aims to advance scientific understanding and improve clinical outcomes in glaucoma management through the development and testing of novel AI-powered tools. Key deliverables include clinical validation of AI models, implementation of decision support systems in diverse healthcare settings, and assessment of their impact on diagnostic accuracy, disease monitoring, and equitable access to care. This work will contribute to the NIH's broader objectives of driving innovation in biomedical research and reducing health disparities.
Generated 4/1/25, 4:43 AM